Townsend & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$910K Hold
7,314
0.08% 70
2026
Q1
$826K Hold
7,314
0.07% 70
2025
Q4
$812K Hold
7,314
0.07% 70
2025
Q3
$620K Hold
7,314
0.06% 76
2025
Q2
$620K Sell
7,314
-1
-0% -$79 0.06% 73
2025
Q1
$569K Sell
7,315
-519
-7% -$48.5K 0.06% 74
2024
Q4
$754K Sell
7,834
-98
-1% -$10.1K 0.08% 71
2024
Q3
$844K Hold
7,932
0.09% 69
2024
Q2
$994K Hold
7,932
0.11% 61
2024
Q1
$1.01M Sell
7,932
-1
-0% -$123 0.12% 62
2023
Q4
$943K Sell
7,933
-1,197
-13% -$124K 0.12% 63
2023
Q3
$939K Sell
9,130
-23,553
-72% -$2.54M 0.2% 62
2023
Q2
$3.51M Sell
32,683
-2,300
-7% -$261K 0.9% 40
2023
Q1
$4.04M Sell
34,983
-14,249
-29% -$1.54M 1.62% 18
2022
Q4
$5.39M Sell
49,232
-1,425
-3% -$146K 2.67% 9
2022
Q3
$5.14M Buy
50,657
+1,647
+3% +$147K 2.38% 4
2022
Q2
$4.62M Buy
49,010
+23,998
+96% +$2.13M 2.14% 4
2022
Q1
$2.19M Buy
25,012
+2,278
+10% +$180K 1.01% 31
2021
Q4
$1.85M Buy
22,734
+419
+2% +$33.4K 1.01% 40
2021
Q3
$1.78M Buy
22,315
+6,340
+40% +$482K 0.88% 38
2021
Q2
$1.24M Sell
15,975
-178
-1% -$13.2K 0.72% 54
2021
Q1
$1.19M Buy
+16,153
New +$1.19M 0.77% 56
2018
Q4
Sell
-409
Closed -$28K 118
2018
Q3
$28K Buy
409
+3
+0.7% +$191 0.03% 109
2018
Q2
$23K Buy
406
+5
+1% +$282 0.03% 111
2018
Q1
$21K Buy
401
+3
+0.8% +$162 0.02% 113
2017
Q4
$21K Buy
+398
New +$22.1K 0.02% 141

Other funds holding MRK

Townsend & Associates's MRK Position: Q2 2026 in Review

Townsend & Associates held its Merck (MRK) position steady in Q2 2026 at 7,314 shares worth $910K. The position accounts for 0.08% of the portfolio, ranked #70.

Townsend & Associates first reported a position in MRK in Q4 2017 and has held it in 26 quarters since. The position peaked at $5.39M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Townsend & Associates held 7,314 shares of Merck worth $910K as of Q2 2026.
  • Townsend & Associates left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.08% of Townsend & Associates's portfolio in Q2 2026, its #70 holding.
  • Townsend & Associates first reported a position in Merck in Q4 2017 and has held it in 26 quarters since.
  • Townsend & Associates's Merck position peaked at $5.39M in Q4 2022.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Townsend & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.